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The purified toxin of Bordetella pertussis was dissociated in 5 M urea in the presence of immobilized hapto- 
globin. The toxin was dissociated in free Si, free Ss and the free complexes S& and Sr-S4, with S& as 
the only haptoglobin-binding moiety, identifying S2 as the haptoglobin-binding protein. Partial NH*-termi- 
nal amino acid sequences were obtained from the dissimilar toxin subunits, after separation by SDS-polyac- 
rylamide gel electrophoresis followed by electrob~otting onto polybrenecoated glass-fiber sheets. The se- 
quences reveal extensive homology of the N-seminal portions of the constitutive subunits Sz and Ss and 
between Si and the enterotoxin A chains of Vibrio cholerae and Esc~erichia coli. 
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1. INTRODUCTION 
Pertussis toxin is a protein toxin produced by 
phase I, virulent strains of Bordetella pertussis 
[l-3]. It can be isolated and purified from the 
culture medium of the bacteria 14-71 and it was 
shown to induce a whole range of biological ac- 
tivities including leukocytosis and lymphocytosis 
[8,9], histamine sensitization [lo], potentiation of 
insulin secretion [ 1 I], lethality, mitogenicity and 
adjuvant effects [ 121. 
PT is an oligomeric protein consisting of six 
subunits, five of which are different from each 
other in molecular mass by polyacrylamide ge1 
analysis in the nresence of SDS. Treating the PT 
with increasing concentrations of urea causes the 
toxin to gradually dissociate into its components 
and has allowed a partial reconstruction of the in-’ 
teraction between the different subunits [13]. Thus 
it has been proposed that PT forms an A-B struc- 
tural organization similar to that of other bacterial 
toxins: the A (active) protomer being subunit Sl 
(M 28000) and catalyzing the ADP-ribosylation of 
the inhibitory guanyl nucleotide component of the 
adenylate cyclase system (G-protein) [14-161; the 
B (binding) oligomer consisting of five subunits: 
one SZ (M 23000), one SS (M 22000), two S4 (M 
11700) and one SS (A.& 9300) and promoting the 
binding of the native toxin to receptor molecules 
allowing the A protomer to reach its site of action 
within the cell. 
A bbreviff#io~s: PT, pertussis toxin; DEAE, As a further study of the molecular nature of the 
~ethylaminoethyl; HPLC, hjgh-perform~ce liquid toxin subunits and the interactions between them, 
chromatography we have analyzed the subunit interactions in the 
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presence of urea and immobilized haptoglobin. We 
also provide the NHz-terminal sequence of the dif- 
ferent subunits and compare the results both with 
each other and with the protein sequences tored in 
the protein sequence data banks. Points of 
homology are discussed. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Chemicals and solvents used in this study were 
either analytical grade or HPLC grade. Urea was 
from Merck, FRG. DEAE-Sepharose CL-6B was 
from Pharmacia, Sweden. Haptoglobin was pur- 
chased from ~~bio~hem-Behring, USA. It was 
. immobilized onto Sepharose according to the pro- 
cedure of Irons and MacLennan [17]. Polybrene 
was obtained from Janssen Biochimica, Belgium 
and used without further purification. Glass-fiber 
sheets (GF/C) were from Whatman, England. 
They were cut from 57 x 46 cm sheets to the size 
of the gel. 
The protein reference mixture was the Bio-Rad 
molecular mass standard mixture. Fluorescamine 
was a product from Fluka, Switzerland. Solvents 
and reagents used for the gas-phase sequenator 
were purchased from Applied Biosystems, USA. 
Solvents used for phenylthiohyd~toin-~no acid 
analysis were from Carlo Erba, Italy. 
2.2. Toxin preparations 
One preparation of pertussis toxin was a com- 
mercially available toxin from List Biological 
Laboratories, USA. A second toxin preparation 
was isolated from the Tohama strain, phase I. 
Therefore Bordeteliapertussis bacteria were grown 
for 50 h at 36°C in modified Stainer-Scholte 
medium containing heptakis (2,6O_dimethyl) & 
cyclodextrin [18,19]. Cells were harvested by cen- 
trifugation and the toxin was purified from the 
culture supernatant according to the procedure of 
Sato et al. [a]. The purity of the PT was checked 
by electrophoresis in 7.5% polyacrylamide gels at 
pH 3.8 [20]; gels were fixed and stained for 16 h at 
room temperature with 0.01% Coomassie blue 
G 250 in 12.5% trichloroacetic acid. 
2.3. Dissociation and separation of the PT subunit 
PT was exposed to 5 M urea for 6 h at 4’C and 
applied to a column of hapto~obin-Seph~ose 4B 
in 0.017 M phosphate buffer (pH 8.3) containing 
5 M urea, The protein fraction which was eluted 
with the same buffer was chromatographed on a 
DEAE-~ph~ose CL-6B column in the same urea 
solution. The material retained by the affinity ad- 
sorbent was eluted by a stepwise change of the buf- 
fer to 0.5 M NaCl/O.l M Tris-HCl (pH 10.0) con- 
taining 3 M KSCN. The subunits of PT were 
analyzed on SDS - containing 15% polyacrylamide 
gels as described by Laemmli [21]. The gels were 
stained with silver according to Wray et al. [22]. 
2.4. Electroblotting on polybrene-coated glass- 
fiber sheets and amino acid sequence analysis 
25 pg of the purified PT were separated on a 
15% gel and the separation was terminated when 
the bromophenol blue reached the edge of the gel. 
The gel was mounted immediately into the blotting 
sandwich, containing two layers of polybrene- 
coated glass-fiber sheets (Whatman GF/C) placed 
back to back on the anodic side of the gel, The 
electrotransfer was carried out as described by 
Vandekerckhove et al. [23]. Blotting was stopped 
after 24 h, the glass-fiber sheets were washed three 
times in 25 mM NaCl, 10 mM borate buffer, pH 
8.0, and dried. Immobilized proteins were detected 
on both sheets using a dilute fluores~~ine stain 
(1 mg/~ ml acetone). Results were recorded by 
photography under UV light using a Polaroid 
camera and a mineral light lamp UV SL 20 (San 
Gabriel, CA). The areas of the glass-fiber carrying 
the proteins were cut out from both sheets and 
placed into the reaction chamber of the gas-phase 
sequenator (Applied Biosystems, USA). The se- 
quenator was run essentially as described by 
Hewick et al. [24]. The stepwise liberated 
phenylthiohyd~toin-Gino acids were identified 
by HPLC analysis using the column and gradient 
system described by Hunkapiller and Hood 1251. 
3. RESULTS AND DISCUSSION 
We have taken advantage of the haptoglobin- 
binding property of PT [17] to develop a rapid 
purification procedure for the five subunits. PT 
(Tohama strain) was treated for 6 h at 4’C in urea 
buffer (see section 2) and loaded onto a column of 
haptoglobin-Sepharose. The protein fraction 
which was not retained in these conditions, was 
analyzed by SDS-polyacryl~ide gel elec- 
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trophoresis and revealed the presence of subunits 
Sr, S3, S4 and SS (fig.l) 
The material binding to haptoglobin was eluted 
by adding 3 M KSCN to the column buffer. This 
fraction contained equal amounts of subunits SZ 
and S4 (fig.1). Proteins from the non-adsorbing 
fraction were further purified on DEAE-Sepharose 
CLdB using the 5 M urea buffer (see above). 
Isocratic elution of the DEAE column with this 
buffer yielded three components (peak I, II and 
III). SDS gel analysis of these fractions showed 
that peak I contained a mixture of S3 and !%I equal- 
ly present, while peaks II and III contained 
subunits Si and SS, respectively (flg.2). Each of the 
dimers, S&, obtained as the haptoglobin-binding 
fraction, and Ss-SS, obtained as the non-adsorbing 
peak I, could be dissociated in 8 M urea and 
separated into their constituent monomers as 
L. 
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Fig. 1. Haptoglobin-Sepharose 4B affinity chromatog- 
raphy of partially dissociated PT. A solution of PT 
(0.5 mg/0.5 ml) in 0.1 M sodium phosphate, pH 7.0, 
0.5 M NaCl, 2 M urea, was dialyzed during 6 h at 4°C 
against 0.017 M phosphate buffer (pH 8.3) containing 
5 M urea. The dissociated toxin was loaded on a 
haptoglobin-Sepharose 4B column (1 x 2.5 cm) which 
was equilibrated with the dialysis buffer. (A) Peak 
fractions obtained by eluting the column with the 
equilibration buffer; (B) material eluting with a step 
gradient of the first buffer to which NaCl (0.5 M) and 
KSCN (3 M) was added and adjusted to pH 10.0. Inset, 
Separation pattern of the affinity separated subunits 
after SDS-polyacrylamide gel electrophoresis. Lanes: 1, 
fraction 20; 2, fraction 25; 3, fraction 27; 4, fraction 67. 
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Fig.2. DEAE-Sepharose CL-6B chromatography of the 
non-haptoglobin binding fraction. Fractions of peak A 
(fig. 1) were combined and loaded on a DEAE-Sepharose 
CL-6B column (1 x 3 cm) equilibrated in 0.017 M 
phosphate buffer (PH 8.3) containing 5 M urea. The 
column was isocratically eluted with a flow rate of 
15 ml/h. Fractions were combined as indicated (peaks 
I-III), dialyzed against 0.05 M ammonium bicarbonate 
and lyophilized. Aliquots were removed and analyzed by 
SDS-polyacrylamide gel analysis (inset). Lanes: 1, 
proteins of peak I; 2, proteins of peak II; 3, proteins of 
peak III. 
described by Tamura et al. [ 131 using DEAE ion- 
exchange chromatography. 
These results differ from those reported 
previously by Tamura et al. [13] where only Sr was 
released from the PT complex (protomer A) leav- 
ing the B oligomer (S&4, S&4 and SS) as the in- 
tact haptoglobin-binding complex. In contrast, we 
find that under identical dissociating conditions as 
described before, PT dissociates into free Sr, free 
SS and the two free dimers Sz4.1 and Ss-S4 with on- 
ly s2-s4 being retained by the haptoglobin column. 
These results suggest hat~in 5 M urea SZ is the only 
haptoglobin-binding subunit. It is also possible 
that complex formation between Sz and S4 is 
necessary to provide the haptoglobin-binding 
capacity to S2. Further protein chemical 
characterization of the PT subunits was made by 
partial amino acid analysis. We therefore sub- 
jected the urea purified proteins to automated 
amino acid sequence analysis using a gas-phase se- 
quenator. We obtained extremely poor sequence 
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information due to very low initial coupling yields 
(less than 1 olo). This is most probably due to exten- 
sive carbamylation taking place during long ex- 
posure to high concentrations of urea. 
The problem of NHz-terminal blocking was cir- 
cumvented by making use of the recently 
developed technique of protein electroblotting on 
polybrene glass-fiber sheets after separation of the 
proteins on SDS-polyacrylamide gels [23]. This 
technique appeared to be extremely valuable in this 
particular case since we could now easily separate 
small amounts of the expensive toxin preparations. 
25 gg of the toxin were separated on a 15 % SDS- 
polyacrylamide gel and electroblotted onto glass- 
fiber sheets. The fluorescamine-stained pattern of 
the immobilized proteins is shown in fig.3. A 
parallel experiment with equal amounts of protein 
allowed one to measure the amount of immobil- 
ized protein (between 80-150 pmol) and to 
i 
c 
d 
Fig.3. Electroblot of the PT subunits from SDS- 
polyacrylamide gel onto polybrene-coated glass-fiber. 
Lanes: A, the PT subunits; B, a standard molecular 
mass protein mixture containing phosphorylase b (a), 
bovine serum albumin (b), ovalbumin (c), carbonic 
anhydrase (d), soybean trypsin inhibitor (e) and 
lysozyme (f). Proteins were separated on a 15% 
polyacrylamide gel. 
calculate sequencing efficiencies. Each of the 
bands was sequenced for 25 steps (SZ only for 15 
steps) and amino acid sequences could unam- 
biguously be allocated to each of these subunits as 
shown in fig.4. This was generally possible for ap- 
prox. 20 residues (+ 10% of the total sequence). 
For subunit SZ, we obtained less sequence informa- 
tion due to low initial coupling yields in the se- 
quence run. 
The blotting experiment was also repeated with 
commercially available toxin (List Biological 
Laboratories, USA; strain unknown). Both strains 
reveal identical NHz-terminal sequences. Subunits 
St and SS are very homologous in their 
NHz-terminal sequences and even identical in posi- 
tions 3-8. This homology is in line with the very 
similar amino acid compoqtion reported previous- 
ly for both subunits [13] and with their ability to 
form an equally stable complex with the same 
subunit Sd. Since S& and SS& differ in their 
haptoglobin-binding capacity (see above), the 
haptoglobin-binding site of SZ should be located in 
the sequence where Sz and S3 differ from each 
other. The present studies only cover the first ten 
amino acid residues of SZ and further experiments 
will be necessary to carry out a more extended 
homology analysis. No further significant 
homology was found between the NH2-termini of 
the remaining subunits. The NHz-terminal se- 
quence of subunit S4 was found to be in complete 
agreement with the sequence which was published 
recently [26]. 
We have also carried out a comparative study 
with the protein sequences tored in the Protein Se- 
quence Data Bank (release 6) of National 
Biomedical Research Foundation (NBRF), 
Washington, DC, USA, using the FASTP pro- 
3 .: ;DPP~TVYR~DSRP~EDVF~NGF 
%: ~TPG~VIPX~EDI 
~3: ~APG~VIPP?ALFT~OGGA 
G: ;VPY~LVKT~~~~VVT?V 
5: ;YSPiDVAG~PTHL~KNFT?Q 
Fig.4. NHZ-terminal sequences of the different subunits 
of pertussis toxin. X denotes a position where no amino 
acid could be detected. 
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Fig.5 Comparison of the NHz-terminal sequence of 
subunit Sr of pertussis toxin with the enterotoxin A 
chains of I’. cholerae (CT) and E. cofi (LT). Amino 
acids are arranged as to obtain the highest degree of 
homology. Identical amino acids are shown in boxes. 
Conserved amino acid exchanges between the proteins 
are given in dotted lines. 
gram. Of the five NHz-terminal sequences com- 
pared, Si showed a high degree of homology with 
the A subunit of I’. choferue toxin (52.7% identity 
in a 17 amino acid overlap) and to a lesser extent 
with the A chain of the E. coli heat-labile 
enterotoxin (58.3% identity in a 12 amino acid 
overlap) (fig.5). These results are in agreement 
with the known functional homology between PT 
subunit Si and the A protomer of the other toxins, 
both identified as catalyzing the ADP-ribosylation 
of G-protein and producing a steady-state level of 
activation of the adenylate cyclase [14-161. 
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